Tesla's Hardware Ambitions Face a Financial Reckoning

Tesla stock surges on AI5 chip completion and EU regulatory win for its Full Self-Driving system, setting a tense stage for Q1 earnings amid analyst concerns over Terafab costs.

Tesla shares surged nearly 8% on Wednesday, closing at around 335 euros, as CEO Elon Musk announced the completion of the AI5 chip design. The stock is now up over 13% for the week, though it remains nearly 10% below its level at the start of the year. This rally sets a tense stage for the company's first-quarter earnings report due on April 22nd.

The so-called "tape-out" for the new AI5 processor is finished, with the blueprint now handed to contract manufacturers TSMC and Samsung for production in their Arizona and Texas facilities, respectively. Musk promises a dramatic leap in capability, touting up to forty times the improvement over the current generation with nine times more memory and eight times the computing power. However, this raw power isn't immediately destined for Tesla's cars. Musk himself stated that the existing AI4 hardware is sufficient for autonomous driving that is significantly safer than a human. The AI5 is instead targeted at the Optimus robot and supercomputer clusters.

Consequently, the upcoming Cybercab, slated for a production start in the second quarter of 2026, will launch with AI4 hardware. A switch to AI5 will only occur once several hundred thousand finished boards are ready, an event not expected until mid-2027 at the earliest.

Alongside chip progress, Tesla secured a crucial regulatory win in Europe. After 18 months of testing, the Dutch vehicle authority RDW granted the first EU approval for Tesla's "Full Self-Driving Supervised" system, allowing it on public roads. Tesla anticipates other EU countries will mutually recognize this approval by summer 2026 without requiring a full new procedure. The service is priced at 99 euros per month or a one-time fee of 7,500 euros. It's important to note this remains a Level-2 system, requiring the driver's constant attention.

Behind these advancements looms the massive "Terafab" project, a planned domestic semiconductor factory involving Tesla, xAI, SpaceX, and Intel, which will contribute its advanced 18A fabrication technology. Reports suggest in-house chip production could slash integrated circuit costs by up to 70%, aiming for drastically faster product development cycles. The financial shadow it casts is a primary concern for analysts. The project was explicitly not included in Tesla's 2026 capital expenditure guidance of $20 billion, which is earmarked for Terafab and robotics. CFO Vaibhav Taneja has promised an update in future quarters.

Analyst sentiment ahead of earnings is mixed. Barclays maintains a price target of $360, below the consensus of around $415, with Terafab's cost being a core worry. UBS recently raised its target to $352, recommending a "hold" position. Market activity reflects the heightened stakes; Wednesday's trading volume hit 113 million shares, roughly 60% above the average. Prediction markets currently assign a 53% probability that Tesla will either miss or only meet profit expectations for the quarter.

While vehicle deliveries rose 6.3% year-over-year to just over 358,000 units last quarter, they still fell short of Wall Street's forecasts. The central question for the April 22nd earnings call is how management will address the enormous investment costs for its chip and fabrication ambitions. Investors need convincing that this expensive hardware strategy will not permanently crush the company's margins. If Musk fails to provide concrete answers on Terafab's capital requirements, the recent share price gains could quickly unravel.